ArticleThe Journal of clinical investigation2022

Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody.

Tanushree Dangi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.